PeptideComb is built upon four decades of rigorous peptide bioregulator research conducted primarily at the St Petersburg Institute of Bioregulation and Gerontology. Our entire product line traces its scientific lineage to the work of Professor Vladimir Khavinson and his research teams, who have published over 700 peer-reviewed papers and registered numerous patents on short peptide bioregulators.
The Khavinson hypothesis emerged from observations that short peptides extracted from young animal tissues could enter cells and modulate physiological protein synthesis in tissue-matched cells. Decades of mechanistic research established that these peptides bind directly to specific gene promoter regions, restoring physiological gene expression that has slowed with age or disease.
Beyond foundational mechanistic work, the bioregulator research program has produced extensive in-vitro studies, animal experiments and clinical observation reports across cardiovascular, immune, neurological, endocrine and dermatological applications. Many publications appear in Russian-language journals; a growing body is now available in English-language gerontology journals.
PeptideComb is committed to transparent scientific communication. We provide direct citations to published research, certificates of analysis on request, and educational content that distinguishes established findings from emerging hypotheses. Our products are manufactured in Germany under pharmaceutical-grade GMP standards.
We believe responsible peptide bioregulator use combines authentic, properly manufactured products with informed customer education and integration into a comprehensive healthy-aging strategy that includes nutrition, exercise, sleep and stress management.
